
San Diego-based Genalyte revolutionizes lab testing with innovative multiplexing technology.
Founded in San Diego, Genalyte is a life sciences company dedicated to revolutionizing lab testing through innovative next-generation multiplexing technology. Their core mission is to simplify and expedite the lab testing process, providing comprehensive results in less than 30 minutes. Genalyte's primary product, Merlin, is designed for research use and aims to transform how doctors make informed decisions by delivering real-time results. The company focuses on enhancing the efficiency and accuracy of lab tests, targeting healthcare providers and patients who require quick and reliable diagnostics.
Genalyte has garnered attention from notable investors and industry leaders, contributing to its rapid growth and development. The company's achievements include significant advancements in multiplexing technology and obtaining necessary clearances and accreditations for their products. By drastically reducing the time required for lab test results, Genalyte has made a substantial impact on the healthcare industry, improving patient care and operational efficiency for medical professionals.

Analyte Health
analytehealth.com

Pleno
plenoinc.com

Fluxergy
fluxergy.com
Gentec

Meru Biotechnologies
merubio.com

Fulgent Diagnostics

Genendeavor
genendeavor.com
SenGenix
sengenix.com

Livingston Med Lab

First Light Diagnostics
firstlightbio.com
LabGenomics Co.

Fulgent Genetics

Heligenics
heligenics.com

BioAnalytics

Select Laboratory Partners
slplabs.com
Companies similar to Genalyte include Analyte Health, Pleno, Fluxergy and Gentec.
Genalyte was founded in 2007.
Genalyte's headquarters is located in San Diego, CA, US.
Genalyte's most recent funding round was for $13M (USD) in March 2023.
As of Mar 7, 2023, Genalyte has disclosed funding of $154.8M (USD). Undisclosed round amounts are excluded.
Genalyte has 150 employees as of Feb 4, 2024.